MENU
LEXX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Lexaria Bioscience (LEXX) Ownership - Who owns Lexaria Bioscience?
Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery... Show more
Profile
Industry
N/A
Address
740 McCurdy Road
Phone
+1 250 765-6424
Employees
5
Web
https://www.lexariabioscience.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
29.31M
P/E Ratio
N/A
Total Cash
8.12M
Projected Growth
N/A
Total Debt
130.73K
Revenue
496.92K
Risk (Beta)
0.93
Dividend Yield
N/A
Total Cash/Share
0.46
Total Debt/Equity
N/A
Revenue/Share
0.03 USD as % of share price
Fundamentals
LEXX
Capitalization
29.3M
P/E Ratio
N/A
Risk (Beta)
0.93
Dividend Yield
N/A
Total Cash
8.12M
Total Cash/Share
0.46
Total Debt
131K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.03%
Revenue
497K
ROE
N/A
Book Value
9.77M
P/B Ratio
3.00
Cash Flow
N/A
Earnings
-0.5
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
17.5K
Current Ratio
29.64
Current Revenue Per Employee
26274.72
Dividends Per Share - Security
N/A
EBITDA
-7.22M
Float
N/A
Float - Current
N/A
Gross Income Margin
98.52
Revenue To Assets
-109.08
Shares Held By Institutions
3.46M
Shares Outstanding - Current
17.6M
Total Liabilities
400K
Total Volume MTD
N/A
Value
N/A
Gain YTD
-21.905
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
740 McCurdy Road
Phone
+1 250 765-6424
Employees
5
Web
https://www.lexariabioscience.com